Frazier Life Sciences Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-85,495
| Closed | -$2.19M | – | 52 |
|
|
2024
Q1 | $2.19M | Hold |
85,495
| – | – | 0.09% | 49 |
|
|
2023
Q4 | $2.36M | Hold |
85,495
| – | – | 0.13% | 46 |
|
|
2023
Q3 | $5.2M | Hold |
85,495
| – | – | 0.35% | 43 |
|
|
2023
Q2 | $5.63M | Buy |
85,495
+13,457
| +19% | +$885K | 0.34% | 40 |
|
|
2023
Q1 | $4.58M | Hold |
72,038
| – | – | 0.33% | 43 |
|
|
2022
Q4 | $9.97M | Hold |
72,038
| – | – | 0.62% | 32 |
|
|
2022
Q3 | $9.12M | Buy |
+72,038
| New | +$9.12M | 0.7% | 31 |
|